Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir Prophylaxis for HBV Reactivation in Rheumatic Patients on Anti-TNFα
NCT01694264Phase 3Terminated
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2012
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of entecavir in hepatitis B (HBV), sponsored by Seoul National University Hospital. Started Sep 2012; status: terminated.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01694264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01694264.